Read + Share
Wirth LJ, Brose MS, Subbiah V, Worden F, et al. Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid
Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. J Clin Oncol 2024;42:3187-3195.
PMID: 39094065
|
 |
|
Wirth LJ, Brose MS, Subbiah V, Worden F, et al. Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid
Cancer: Long-Term Safety and Efficacy From LIBRETTO-001. J Clin Oncol 2024;42:3187-3195.
PMID: 39094065
|
|
|
|